India Commerce Official To Hold Meeting With U.S. Pharma
This article was originally published in PharmAsia News
Executive Summary
India's Commerce Secretary Rajeev Kher is expected to meet with U.S. drug makers to discuss the use of compulsory licensing and denial of patents considered to lack innovation.